• Corpus ID: 13667037

Moisturisation in the Management of Paediatric Atopic Dermatitis

  title={Moisturisation in the Management of Paediatric Atopic Dermatitis},
  author={John Su},
Issue 18 – 20 15 Abbreviations used in this issue PASI = Psoriasis Area a nd Severity Index PASI 75 = 75% reducti on in PASI score For more informatio n, please go to http ://www.medsafe.go vt.nz Independent comment ary by Associate Profe ssor Amanda Oakley, a specialist dermatologist in Hamil ton and an Honorary As sociate Professor at Wa ikato Clinical School (Auckland Unive rsity School of Medicin e). For full bio CLICK H ERE. DERMATOLOGY RESEARCH REVIEW IS BROUGHT TO YOU BY RESEARCH REVIEW… 

Figures and Tables from this paper


Use of emollients in atopic dermatitis
Emollients hold the potential to act as steroid‐sparing agents, but more well‐designed studies are pertinent for a definite conclusion, and primary prevention of AD by regular application of emollients in high‐risk infants cannot yet be recommended.
Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy
The role of emollients in the management of atopic dermatitis, with particular emphasis on infants and young children, is discussed.
Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis.
These studies found that the daily use of moisturizers and/or cleansers containing colloidal oatmeal significantly improved many clinical outcomes of atopic dermatitis from baseline: investigator's assessment (IGA), eczema area and severity index (EASI), itch, dryness, and quality of life indices.
Benefits of mild cleansing: synthetic surfactant based (syndet) bars for patients with atopic dermatitis.
Syntet bar use reduced the severity of eczematous lesions, improved skin condition, and maintained hydration, indicating that syndet formulations are compatible with the therapy of AD.
Cost-effectiveness of Prophylactic Moisturization for Atopic Dermatitis
Daily moisturization may represent a cost-effective, preventative strategy to reduce the burden of atopic dermatitis.
The Steroid-Sparing Effect of an Emollient Therapy in Infants with Atopic Dermatitis: A Randomized Controlled Study
The emollient treatment significantly reduced the high-potency topical corticosteroid consumption in infants with AD, and infants’ and parents’ quality of life significantly improved.
Emollients and moisturisers for eczema.
Assessing the effects of moisturisers for eczema found that with Atopiclair, 174/232 participants experienced improvement in participant-assessed disease severity versus 27/158 allocated to vehicle, with equal satisfaction between the two groups.
Barrier Repair Therapy in Atopic Dermatitis: An Overview
Some evidence that certain products had therapeutic efficacy in improving clinical and/or biophysical parameters of patients with AD is found, but study methods were often flawed and sample sizes were small.
[Atopic dermatitis in children].
Atopic dermatitis is a chronic inflammatory and recurrent dermatosis, the frequency of which increases regularly in industrialised countries, and the clinical presentation changes with the age of the child.
New Emollient with Topical Corticosteroid‐Sparing Effect in Treatment of Childhood Atopic Dermatitis: SCORAD and Quality of Life Improvement
A twice daily application of a new natural emollient provided a major corticosteroid sparing, improved lichenification and excoriation and improved the quality of life in children and their parents.